Distinct molecular subtypes of KRASG12C‐mutant lung adenocarcinoma: Insights into clinical outcomes, tumour microenvironments and therapeutic strategies.
Saved in:
| Title: | Distinct molecular subtypes of KRASG12C‐mutant lung adenocarcinoma: Insights into clinical outcomes, tumour microenvironments and therapeutic strategies. |
|---|---|
| Authors: | Yang, Haitang1,2 (AUTHOR), Zhu, Anshun3 (AUTHOR), Niu, Yongliang4 (AUTHOR), Ma, Wenyan5 (AUTHOR), Xu, Ke1 (AUTHOR), Jia, Yunxuan1 (AUTHOR), Xu, Weijiao1,2 (AUTHOR), Zhao, Baicheng1,2 (AUTHOR), Zhang, Enshuo1,2 (AUTHOR), Jia, Jiaying3 (AUTHOR), Liang, Shunqing6 (AUTHOR), Dorn, Patrick7,8 (AUTHOR), Liu, Gang1,3 (AUTHOR) liugang8@shchest.org, Peng, Ren‐Wang7,8 (AUTHOR) Renwang.Peng@insel.ch, Yao, Feng1,2,3 (AUTHOR) yaofeng@shsmu.edu.cn |
| Source: | Clinical & Translational Medicine. Oct2025, Vol. 15 Issue 10, p1-27. 27p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 20011326 |
|---|---|
| DOI: | 10.1002/ctm2.70490 |
